|
China Tianying Inc. (000035.SZ) DCF Valuation
CN | Industrials | Waste Management | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
China Tianying Inc. (000035.SZ) Bundle
Enhance your investment strategies with the China Tianying Inc. (000035SZ) DCF Calculator! Explore actual financial data, adjust growth projections and expenses, and observe how these modifications affect the intrinsic value of China Tianying Inc. (000035SZ) in real-time.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18,587.1 | 21,867.5 | 20,592.7 | 6,706.7 | 5,323.6 | 7,457.9 | 10,447.9 | 14,636.7 | 20,504.7 | 28,725.3 |
| Revenue Growth, % | 0 | 17.65 | -5.83 | -67.43 | -20.62 | 40.09 | 40.09 | 40.09 | 40.09 | 40.09 |
| EBITDA | 3,504.0 | 4,218.9 | 3,669.4 | 1,101.3 | 1,581.2 | 1,522.7 | 2,133.2 | 2,988.4 | 4,186.5 | 5,864.9 |
| EBITDA, % | 18.85 | 19.29 | 17.82 | 16.42 | 29.7 | 20.42 | 20.42 | 20.42 | 20.42 | 20.42 |
| Depreciation | 1,986.1 | 2,143.6 | 1,824.1 | 591.7 | 804.3 | 794.7 | 1,113.3 | 1,559.6 | 2,184.9 | 3,060.8 |
| Depreciation, % | 10.69 | 9.8 | 8.86 | 8.82 | 15.11 | 10.66 | 10.66 | 10.66 | 10.66 | 10.66 |
| EBIT | 1,517.9 | 2,075.3 | 1,845.3 | 509.6 | 776.9 | 728.0 | 1,019.9 | 1,428.8 | 2,001.6 | 2,804.1 |
| EBIT, % | 8.17 | 9.49 | 8.96 | 7.6 | 14.59 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 |
| Total Cash | 3,811.3 | 3,395.9 | 3,876.4 | 1,957.9 | 1,379.4 | 1,640.2 | 2,297.8 | 3,219.0 | 4,509.5 | 6,317.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6,920.0 | 6,333.9 | 1,251.1 | 2,317.8 | 2,601.1 | 2,322.2 | 3,253.3 | 4,557.5 | 6,384.7 | 8,944.4 |
| Account Receivables, % | 37.23 | 28.96 | 6.08 | 34.56 | 48.86 | 31.14 | 31.14 | 31.14 | 31.14 | 31.14 |
| Inventories | 634.1 | 760.2 | 495.7 | 422.2 | 315.1 | 320.8 | 449.4 | 629.6 | 882.1 | 1,235.7 |
| Inventories, % | 3.41 | 3.48 | 2.41 | 6.29 | 5.92 | 4.3 | 4.3 | 4.3 | 4.3 | 4.3 |
| Accounts Payable | 5,687.7 | 3,931.2 | 2,560.5 | 2,988.6 | 2,994.4 | 2,413.7 | 3,381.4 | 4,737.0 | 6,636.1 | 9,296.7 |
| Accounts Payable, % | 30.6 | 17.98 | 12.43 | 44.56 | 56.25 | 32.36 | 32.36 | 32.36 | 32.36 | 32.36 |
| Capital Expenditure | -3,552.5 | -3,522.0 | -2,748.3 | -3,823.4 | -2,410.3 | -2,250.0 | -3,152.1 | -4,415.8 | -6,186.2 | -8,666.3 |
| Capital Expenditure, % | -19.11 | -16.11 | -13.35 | -57.01 | -45.28 | -30.17 | -30.17 | -30.17 | -30.17 | -30.17 |
| Tax Rate, % | 19.76 | 19.76 | 19.76 | 19.76 | 19.76 | 19.76 | 19.76 | 19.76 | 19.76 | 19.76 |
| EBITAT | 1,023.4 | 1,075.6 | 1,159.7 | 251.2 | 623.4 | 453.8 | 635.7 | 890.6 | 1,247.6 | 1,747.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,409.4 | -1,599.2 | 4,212.1 | -3,545.6 | -1,153.0 | -1,309.2 | -1,495.1 | -2,094.5 | -2,934.2 | -4,110.6 |
| WACC, % | 5.49 | 5.19 | 5.4 | 5.15 | 5.74 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -9,916.1 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | -4,234 | |||||||||
| Terminal Value | -176,779 | |||||||||
| Present Terminal Value | -135,935 | |||||||||
| Enterprise Value | -145,851 | |||||||||
| Net Debt | 5,460 | |||||||||
| Equity Value | -151,311 | |||||||||
| Diluted Shares Outstanding, MM | 2,409 | |||||||||
| Equity Value Per Share | -62.80 |
What You Will Receive
- Authentic China Tianying Data: Pre-filled financials – covering everything from revenue to EBIT – based on real and projected metrics.
- Comprehensive Customization: Modify all key parameters (yellow cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Revisions: Automatic recalculations to evaluate how changes affect the fair value of China Tianying Inc. (000035SZ).
- Flexible Excel Template: Designed for swift modifications, scenario analyses, and in-depth forecasts.
- Efficient and Precise: Avoid the hassle of creating models from the ground up, while ensuring accuracy and adaptability.
Key Features
- Pre-Configured Data: China Tianying Inc.'s historical financial reports and pre-populated projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Instantly view the intrinsic value of China Tianying Inc. recalculating live.
- Intuitive Visual Outputs: Dashboard graphs showcase valuation outcomes and important metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Functions
- Step 1: Download the ready-to-use Excel template containing data for China Tianying Inc. (000035SZ).
- Step 2: Review the pre-filled worksheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and parameters in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the updated results, including the intrinsic value of China Tianying Inc. (000035SZ).
- Step 5: Use the outputs to make well-informed investment choices or to create reports.
Why Choose This Calculator for China Tianying Inc. (000035SZ)?
- All-in-One Solution: Incorporates DCF, WACC, and financial ratio analyses in a single tool.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for China Tianying Inc.
- Preloaded Information: Access to historical and projected data for precise calculations.
- High-Quality Standards: Designed for financial analysts, investors, and business consultants alike.
Who Should Utilize This Product?
- Investors: Assess China Tianying Inc.'s (000035SZ) valuation prior to making stock trades.
- CFOs and Financial Analysts: Optimize valuation workflows and evaluate financial projections.
- Startup Founders: Understand valuation methodologies used by established companies like China Tianying Inc. (000035SZ).
- Consultants: Provide clients with expert valuation reports based on China Tianying Inc. (000035SZ).
- Students and Educators: Leverage real-world examples to practice and teach valuation strategies related to companies like China Tianying Inc. (000035SZ).
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for China Tianying Inc. (000035SZ), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated worksheet for calculating the Weighted Average Cost of Capital (WACC), featuring key parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that illustrate intrinsic value along with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to facilitate thorough analysis.
- Key Ratios: A collection of key profitability, leverage, and efficiency ratios specifically for China Tianying Inc. (000035SZ).
- Dashboard and Charts: A visual summary showcasing valuation outputs and assumptions to simplify result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.